FTC Drops Hammer On Skin Care Sellers For Deceptive 'Risk Free' Trials
This article was originally published in The Tan Sheet
A federal court issues a temporary restraining order in response to FTC's complaint citing seven individuals and a "maze of interrelated shell companies" for deceptive "risk-free" skin-care trial offers. Buried in fine print on the companies' websites were terms specifying charges for unsuspecting consumers, FTC says.
You may also be interested in...
FTC sends refunds totaling $60,791 to purchasers of Nobetes' product touted as diabetes treatment and $113,000 for purchases of FlexiPrin, a deceptively marketed joint pain supplement. Commission previously settled with both firms.
In a presentation at the National Advertising Division Annual Conference, FTC Chairwoman Edith Ramirez discussed the commission’s priorities for the year ahead. Health claims and inadequate disclosures top the list following related settlements with advertisers in 2013 and the agency’s Operation Full Disclosure initiative.
On the heels of FTC’s “Operation Full Disclosure,” which resulted in 60 warning letters, commission officials advise all advertisers to pay close attention to their disclosures and ensure they are clear and conspicuous. The initiative included review of 1,000 national television and print ads, and the agency says it will continue to monitor the advertising landscape for inadequate disclosure use.